Project Grant R03DA065862
- Federal Grant Award Summary Brown University received a $147,486 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded October 18, 2025, with a completion date of August 31, 2027. The award funds a statewide examination of address-level relationships between residential eviction proceedings and overdose events in Rhode Island. The research will construct a longitudinal dataset by linking administrative records from...
- Federal Project Grant Award Summary Brown University received a $2.69 million Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded on September 1, 2025, and extending through May 31, 2030. The project, titled "Optimizing Methadone Treatment Strategies for Opioid Use Disorder in the Era of Fentanyl," will conduct longitudinal effectiveness and safety research to evaluate different methadone treatment...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Columbia University a $1.51M Project Grant (CFDA 93.279: Drug Use and Addiction Research Programs) on August 15, 2025, to develop and pilot an integrated HIV/Overdose Education and Naloxone Distribution (OEND) peer navigation intervention targeting Latinx people who use and sell drugs (PWUSD) in Kensington, Philadelphia. The R34 pilot study will train 45 PWUSD in naloxone use and distribution while linking...
- Federal Grant Award Summary Princeton University received a $164,000 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded August 15, 2025, with completion targeted for July 31, 2027. The award supports development of a Chemical Artificial Intelligence (AI) and Data Science Platform designed to identify and discover novel psychoactive substances (NPS). The project will deliver three primary products: (1) a...
- Federal Project Grant Award Summary Tufts University School of Medicine received a $386,500 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) on September 15, 2025, with completion scheduled for August 31, 2027. This R21 exploratory grant funds fundamental neuroscience research investigating the neurobehavioral consequences of fentanyl overdose and their relationship to relapse risk in individuals with opioid use...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of California, San Diego $2,312,059 under the Drug Use and Addiction Research Programs (CFDA 93.279) on August 1, 2025, for a five-year project period extending through April 30, 2030. The grant supports "Breaking Barriers: Innovating HIV Elimination with Social Network Strategies and Routine Substance Use Screening," a hybrid Type I clinical trial designed to identify and engage...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $438,950 under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Board of Regents of the University of Nebraska, operating through the University of Nebraska Medical Center (UNMC) in Omaha. The award, made on May 1, 2026, supports an R21 exploratory/developmental research grant with a project completion date of April 30, 2028. The research investigates the mechanisms underlying polysubstance use (PSU)...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Rhode Island Research Office a $296,112 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct mixed-methods research examining clinician stigma as a barrier to buprenorphine treatment for opioid use disorder (OUD) among veterans. The study, titled "Bridging the Gap: Understanding Clinician Stigma in Buprenorphine Prescribing and Its Influence on Treatment...
- Federal Grant Award Summary American University received a $476,496 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning August 15, 2025, and concluding July 31, 2028. The grant funds fundamental neuroscience research investigating opioid signaling mechanisms in reward-guided decision-making within the rat prefrontal cortex, specifically the prelimbic area. The research employs a two-alternative forced choice...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded UC San Diego a $1,118,834 Project Grant on May 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and implement an innovative community-informed modeling framework addressing HIV and Hepatitis C Virus (HCV) prevention resource allocation for people who use drugs (PWUD). The project will deliver a novel integrated system comprising: (1) artificially intelligent...
Brown University received a $159,500 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded May 15, 2026, with a completion date of April 30, 2028. The award supports a pilot study investigating how drug use network characteristics influence engagement with overdose prevention programs (OPPs) among people who use unregulated drugs in Rhode Island. The research addresses a significant knowledge gap by examining social network effects on program utilization, moving beyond prior studies that focused solely on individual-level predictors. The study will enroll 100 participants and employ structured egocentric network methods to assess the relationship between drug use network features and OPP engagement. This research is nested within an ongoing evaluation of Rhode Island's first overdose prevention program and directly supports NIDA's mission to develop new knowledge and approaches for overdose prevention and harm reduction. Given the evolving composition of unregulated drug supplies—increasingly containing fentanyl, non-opioid sedatives, and local anesthetics—the project contributes critical evidence to inform implementation of comprehensive OPP models that integrate overdose risk reduction services, naloxone provision, infectious disease testing, and wraparound social support services. Research findings will inform evidence-based strategies to maximize engagement with life-saving overdose prevention interventions.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $159.5k | 5/12/26 |